Avandia REMS Limits Access To Mail Order Pharmacies Beginning In November
This article was originally published in The Pink Sheet Daily
Executive Summary
The Risk Evaluation and Mitigation Strategy for all rosiglitazone-containing products also requires prescriber, pharmacy and patient enrollment as well as special certification for distributors.